1. Demographic characteristics of the 1902 transthyretin amyloid cardiomyopathy patients treated by tafamidis through the French early access program. (14th October 2021) Authors: Lairez, O; Reant, P; Habib, G; Jeanneteau, J; Eicher, J C; Jobbe Duval, A; Lequeux, B; Bauer, F; Bartoli, M; Noirot-Cosson, C; Rudant, J; Kharoubi, M; Damy, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk of atrial fibrillation in hypertrophic cardiomyopathy: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY). (8th February 2021) Authors: Hourqueig, M; Bouzille, G; Mirabel, M; Huttin, O; Damy, T; Labombarda, F; Eicher, J-C; Charron, P; Habib, G; Reant, P; Hagege, A; Donal, E Journal: European heart journal Issue: Volume 22(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Validation of a deep learning algorithm identifying diagnostic quality cardiac ultrasound reference views during search phase. (4th February 2022) Authors: Moal, O; Roger, E; Reant, P; Dezellus, A; Tavernier, M; Moal, B; Lafitte, S Journal: European heart journal Issue: Volume 23(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗